How can companies measure the impact of their investment in cancer research?
Companies can measure the impact of their investment in cancer research through various metrics. Key performance indicators (KPIs) might include the number of new drugs or treatments developed, the progression of clinical trials, and the number of patents filed. Companies can also track improvements in patient outcomes, such as increased survival rates and better quality of life. Financial metrics, such as return on investment (ROI) and revenue generated from new products, are also important indicators of success.
